NXS - Next Science

[Dona Ferentes]

and a bit later on, (meandering down the DNH path), we see NXS has dropped from $3+ a few years ago to 70c in June.

Today, a bit of a lift, from 80c to $1.05 based on a strong Quarterly?

• Product sales Q2 2022 +99% vs pcp, 70% on Q1 2022
• Signed multiple new distribution agreements in the Quarter to expand commercial reach and support for clinicians

Still a bit too much of the aspirational wording

A strategy to accelerate market awareness and adoption

 

[barney]

Still a bit too much of the aspirational wording

Yeah possibly so @Dona Ferentes i know nothing about the Company. A quick squiz at my initial "indicators" shows

Market Cap of around $206M Cap raise around March and currently have around $12M in the bank

Wide range bar on over average Volume, with a fair upper tail on todays +23% jump off recent lows

(Appropriate caution required at this stage would be my gut feel)

 

[Dona Ferentes]

(Appropriate caution required at this stage would be my gut feel)

Managed a lift today on an early update... (still 'investing in sales and marketing' though)

In advance of the forthcoming Appendix 4C and quarterly activity report, Next Science notes continuing improvement in the performance of the business across the quarter-to-date. Next Science advises, that with a few days left in the month, unaudited product sales for 2QFY23 are expected to be above US$5.6m. This compares with reported product sales of US$4.4m in 1QFY23.

As the period for 1HFY23 is about to close, it is clear, that Next Science is on track to substantially exceed product sales in 1HFY22 (US$5.2m) and 2HFY22 (US$6.1m). This is due to the increased investment in sales and marketing that will continue during the establishment phase of our direct sales model for key products.

As noted in the Chair’s AGM address on 26 May 2023, monthly sales in the Wound Care DME business surpassed $1m in April. Operating momentum has continued through the current quarter with ongoing evidence of sales traction in the commercial wound care market.

 

[Dona Ferentes]

Glimmer of an uptick, in price if not volume, and along comes a TH

Capital raising by way of a placement and a share purchase plan

 

[Dona Ferentes]

quarterly and investor update out, and down she goes ⬇

.
5 year chart looks even worse

NH